Evercore Q2 FY26 net income falls 1.98% to $95.3 million; net revenues rise 19% to $990.2 millionPUBT·2 hours agoEVR+0.11%
Evercore Reports Second Quarter 2026 Results; Quarterly Dividend of $0.89 Per Share | EVR Stock NewsStockTitan·10 hours agoEVR+0.11%
Dyne Therapeutics closes upsized public offering of 21,045,000 shares at $20.5 eachPUBT·Jul 23 at 03:29 PMDYN+1.05%EVR+0.11%
Lyntris Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering | LYNX Stock NewsStockTitan·Jul 23 at 10:27 AMBAC+0.79%C-0.47%
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock | DYN Stock NewsStockTitan·Jul 21 at 01:46 PMDYN+1.05%JEF+1.76%
